| I |
| Iaboni S. |
- |
Computer assisted VKA monitoring with point of care device by general practitioners |
| |
- |
Prospective assessment of clinical endpoints of VKA treatment in a primary care computer assisted management model |
| Iacobelli M. |
- |
Defibrotide blunts the pro-thrombotic effect of thalidomide on endothelial cells |
| |
- |
Extended administration of defibrotide in non-immunogenic extended studies in rats and dogs |
| Iacobellis N. |
- |
Evidence of the first X-linked thrombophilia due to a novel mutation in clotting factor IX gene resulting in hyperfunctional fix: factor IX arginine 338 leucine (factor IX padua) |
| Iacoviello L. |
- |
Leptin enhances tissue factor synthesis in the human breast cancer cell line MCF7 |
| |
- |
Pulmonary function, C-reactive protein and cardiovascular risk in the moli-sani population |
| |
- |
Genetic regulation of inflammation-mediated haemostasis activation: a family-based approach |
| |
- |
Thrombotic complications in adult patients with lymphoma: a meta-analysis |
| |
- |
Human blood platelet function and proteome following chronic intake of orange juice |
| |
- |
Whole blood procoagulant activity in healthy volunteers is decreased following orange juice intake |
| |
- |
Whole blood procoagulant activity as a possible cellular marker of cardiovascular risk |
| Iakova P. |
- |
In vitro evaluation of artificial membrane biocompatibility |
| Iannaccaro P. |
- |
Ischemic heart disease in haemophiliac patients |
| |
- |
Lupus anticoagulant in a patient with Haemophilia A |
| |
- |
Haemophilia and invasive coronary procedures |
| Iannaccone A. |
- |
JAK2 V617F mutation is not associated with pregnancy loss: a nested case-control study |
| Iannuzzi F. |
- |
Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the meld score |
| Iasella M. |
- |
A complex management of anticoagulant therapy in a 70-year-old woman suffered concomitantly and subsequently from acute lifethreatening digestive bleeding, deep venous thrombosis, heparin induced thrombocytopenia and a transabdominal drainage of a liver |
| Iatmanen S. |
- |
Protease nexin-1 is anti-angiogenic in vitro independently of its anti-protease activity |
| Iba T. |
- |
Enoxaparin attenuates endothelial damage with less bleeding compared to unfractionated heparin in endotoxemic rats |
| Ibarra A. |
- |
Induction of pathogenic antiphospholipid antibodies in vivo are dependent on expression of MHC-II genes |
| Ibghi D. |
- |
Single administration of idrabiotaparinux has no effect on digoxin pharmacokinetics in healthy subjects |
| Ibrahim B. |
- |
Why do we evaluate pt and aptt before delivery? |
| Ichikawa H. |
- |
Identification of critical residues in the 558-loop of factor VIIIA A2 subunit in the interaction with factor IXA |
| Ichinose A. |
- |
Gamma-glutamyl carboxylase is a cargo receptor for vitamin K-dependent proteins |
| Ido M. |
- |
Src and PI3-kinase transmit signals leading to CK2 activation in PAR1-Ap-stimulated platelets |
| Ieko M. |
- |
Nicked beta2-glycoprotein I, but not intact beta2-glycoprotein I, binds plasminogen proteolysis product angiostatin4.5 and reduce its physiological properties |
| Iglesias Varela M. |
- |
The importance of appropriated criteria for lupus anticoagulant (LA) diagnosis |
| Iglesias Varela M.L. |
- |
ABO blood group as a risk factor for venous thrombosis |
| Ignjatovic V. |
- |
Do bolus doses of UFH contribute to increased bleeding risks in children? |
| |
- |
Unfractionated heparin has an age-dependent pharmacokinetic profile in children |
| |
- |
Developmental differences in procoagulant phosholipid/microparticle concentration |
| |
- |
Thrombin generation and fibrinolysis parameters in boys with severe haemophilia A |
| |
- |
Compliance of antithrombotic management with paediatric guidelines |
| |
- |
Low molecular weight heparin (LMWH) response in children |
| |
- |
Age-related differences in the binding of unfractionated heparin (UFH) to plasma proteins |
| |
- |
Automated anti-factor IIa assay for monitoring unfractionated heparin (UFH) |
| |
- |
Thrombin generation in children on oral anticoagulants |
| |
- |
Evaluation of point of care INR in children |
| |
- |
Age-related differences in in vivo UFH response in children |
| |
- |
Anti-Xa:anti-IIa ratio varies with age and UFH concentration in children |
| |
- |
Correlation of UFH measures of effect with protamine titration in children |
| |
- |
Altered reference ranges for protein C and protein S during early pregnancy: implications for diagnosis of their deficiency during pregnancy |
| |
- |
The significance of snake venom and antivenom specificity in human plasma |
| |
- |
Dosing of LMWH (enoxaparin) therapy in children |
| Iijima K. |
- |
Identification of mutation site and functional characterization of abnormal protein C-tottori |
| Ikeda Y. |
- |
GSK-3β negatively regulates thrombopoiesis in an in vitro normal human CD34-positive cell-derived differentiation system |
| Ikeda R. |
- |
Interference of platelets in plasma on the APTT mixing test |
| Ikeda Y. |
- |
PKC-MMP-14 axis regulates endothelial soluble Tie-2 (sTie-2) production: involvement of stie-2 in diabetes mellitus-associated vascular complications |
| |
- |
Development of thrombopoietin receptor agonists for clinical use |
| |
- |
National questionnaire survey of TMA |
| Ikeda T. |
- |
The anti-platelet effect of aspirin does not decrease after 2-year interval |
| Ikeda Y. |
- |
An inhibitory role of platelet CD109 in platelet function |
| |
- |
Effect of aspirin administration on GPIb alpha shedding: association of glycocalicin level with platelet sensitivity to aspirin |
| |
- |
Could D-dimer in the type 2 diabetic patients be a marker of the macrovascular complications? |
| Ikenaga H. |
- |
A possible mechanism of faster onset of prasugrel – the intestine as an important contributor to the active metabolite formation in vivo |
| Ikram N. |
- |
vWF:Ag and FVIII levels in the patients with von Willebrand disease: a single center study |
| Ilas J. |
- |
Opportunities and limitations of mouse models humanized for HLA class II antigens |
| Ilic V. |
- |
Acquired von Willebrand syndrome in patients with multiple myeloma |
| Iliceto S. |
- |
Standardized low molecular weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study |
| Iliescu V. |
- |
The clinical significance of heparin/platelet factor 4 antibodies after cardiac surgery |
| Iliuta L. |
- |
The clinical significance of heparin/platelet factor 4 antibodies after cardiac surgery |
| Ilonczai P. |
- |
Stem cell therapy in the treatment of Buerger's disease: a new and prospective approach |
| Imaeda Y. |
- |
Effects of TAK-442, a direct factor XA inhibitor, and fondaparinux on platelet-associated prothrombinase in the balloon injured artery of rats |
| |
- |
Antithrombotic profiles of TAK-442, a novel oral factor Xa inhibitor, in venous and arterial thrombosis models |
| |
- |
Synergistic effect of TAK-442, a direct factor Xa inhibitor, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats |
| |
- |
Differential effects of TAK-442, a factor Xa inhibitor, and ximelagatran, a thrombin inhibitor on factor V-mediated feedback on coagulation cascade and bleeding |
| Imai M. |
- |
Fermentation of royal jelly and bee pollen : nattokinase fibrinolysis and vitamin K2 content |
| Imamura T. |
- |
Disturbed blood flow induces erosive injury of tissue factor-rich intima and promotes thrombus formation |
| Imanishi T. |
- |
Impact of in vivo platelet activity on subclinical stent thrombosis: an optical coherence tomography study |
| Imanishi D. |
- |
The severity of bleeding symptoms in factor V deficiency caused by a novel compound heterozygous mutation (P1618R and IVS7 + 5 G > C) |
| Imbergamo S. |
- |
Tadalafil in patients with erectile dysfunction and cardiovascular risk factors: effects on platelets and endothelium |
| Imberti D. |
- |
A randomized, prospective, open-label study on distal vein thrombosis (low-molecular-weight heparin vs. warfarin for 6 weeks): the todi study |
| |
- |
LMWH vs. aspirin for the treatment of acute retinal vein occlusion |
| |
- |
Prognostic relevance of asymptomatic VTE in cancer patients |
| Imfeld K.L. |
- |
Tissue factor promoter D/D haplotype amplifies inflammatory response via p38-mapk in neonatal compared to adult human microvascular endothelial cells (HMVEC) |
| |
- |
The effect of immune thrombocytopenic purpura (ITP) plasma on megakaryocytopoiesis in vitro: comparison of pre versus post diagnosis plasma |
| Immenschuh S. |
- |
Anti-dengue NS1 antibody induces heme oxygenase-1 gene expression in endothelial cells |
| Inaba H. |
- |
Identification and characterization of a novel adenine to guanine transition in intron 10 of the factor VIII gene as a candidate causative mutation of mild hemophilia A |
| |
- |
The severity of bleeding symptoms in factor V deficiency caused by a novel compound heterozygous mutation (P1618R and IVS7 + 5 G > C) |
| Inagaki M. |
- |
Clopidogrel and prasugrel prolong primary hemostasis in the mouse beyond levels associated with P2Y12 inhibition |
| |
- |
Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors |
| Inami N. |
- |
Eicosapentaenoic acid improves adiponectin, endothelial cell-derived microparticles and angiopoietin-2 in patients with type 2 diabetes |
| |
- |
Adiponectin-dependent effects of pitavastatin on platelet-derived microparticles, soluble CD40 ligand and MCP-1 in hyperlipidemic patients |
| Inbal A. |
- |
ANTI-GPIIbIIIa-induced acquired thrombasthenia in a patient with sle |
| Incampo F. |
- |
TAFI-dependent inhibition of fibrinolysis by platelets evaluated in whole blood by thromboelastography |
| Ingalls R. |
- |
Inflammatory modulation of megakaryocytes and thrombopoiesis through TLR2 and IL1R |
| Ingerslev J. |
- |
Stored platelet pools lose their ability to facilitate aggregation but maintain their support of clot formation as evaluated in a model of whole blood thrombocytopenia |
| |
- |
Inhibitory antibodies against factor VII:C in factor VII deficiency. 2009 interim data analysis report from the central laboratory facility of the seven treatment evaluation registry (STER) |
| |
- |
Mechanisms of dilutional coagulopathy |
| |
- |
The combination of recombinant factor VIIa and fibrinogen corrects coagulation in a model of whole blood thrombocytopenia |
| |
- |
Development of a laboratory model of post cardiac coagulopathy |
| |
- |
Current practice in management of muscle haematoma in patients with severe haemophilia |
| |
- |
Hepatitis C in haemophilia – predictive values of coagulation factor activities in prediction of fibroscan verified cirrhosis |
| |
- |
Haemostatic response to in vitro addition of recombinant factor VIIa, prothrombin complex concentrate, or concentrate of Factor IX/X in blood spiked with a direct Xa inhibitor |
| |
- |
Establishment of a european network of rare bleeding disorders (EN-RBD database): preliminary results on 190 patients |
| |
- |
A case-controlled danish-russian comparative study of clinical outcomes in younger severe haemophilia patients treated with prophylaxis compared to those managed with on-demand treatment |
| Ingle A. |
- |
Lack of aspirin resistance in pregnant women |
| |
- |
Evaluation of an automated assay for soluble fibrin monomers |
| Ingram A.J. |
- |
Low-intensity adjusted-dose warfarin for the prevention of mechanical malfunction of double-lumen haemodialysis catheters: a randomized controlled trial |
| Ingratti M. |
- |
Acquired factor X (FX) deficiency, chronic lymphocytic leukaemia (CLL) and amyloidosis (A) |
| Innocenti P. |
- |
Age-dependent impairment of number and angiogenic potential of adipose tissue – derived progenitor cells |
| Innocenti M. |
- |
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the two coagulation disorders |
| Inoue O. |
- |
A role of platelet membrane microdomains in CLEC-2-mediated signal transduction |
| Inoue H. |
- |
Randomized, parallel group, warfarin control, multicenter phase II study evaluating safety of DU-176b in Japanese subjects with non-valvular atrial fibrillation (NVAF) |
| Inoue Y. |
- |
Are platelets phagocytes or covercytes? An ultrastructural study of interaction between Porphyromonas gingivalis, an oral bacterium and human platelets |
| Inoue O. |
- |
Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI |
| |
- |
Soluble elastin inhibits platelet activation mediated through glycoprotein Ib |
| Inoue M. |
- |
Clinical background of acute ischemic stroke patients with extremely high level of serum D-dimer |
| Interthal C. |
- |
Activated thrombin activatable fibrinolysis inhibitor (TAFIA) levels in high pregnancy |
| Inwards D.J. |
- |
Low risk for symptomatic venous thromboembolic events (VTE) during cytokine administration for peripheral blood stem cell mobilization |
| Inzitari D. |
- |
Bone marrow-derived progenitor cells in ischemic stroke patients: relationship between infarct size, neurological impairment and discharge outcome |
| Iommi P. |
- |
Platelet aggregation and coagulation disorders in ehlers-danlos syndrome |
| Ionescu-Zanetti C. |
- |
A microfludic system designed to observe platelet behavior under controlled shear in real time |
| Ionita H. |
- |
Locomotor status – clinical expression of the quality of care in hemophilia – multicentric study |
| Iorio A. |
- |
Bone mineral density in hemophilia patients: a meta-analysis |
| |
- |
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results |
| |
- |
Multicentric evaluation of current dosing practice of recombinant fix in italy |
| |
- |
D-dimer to predict thrombosis recurrence: comparison of aggregate data and individual patient data meta-analyses |
| |
- |
D-dimer to predict thrombosis recurrence after unprovoked venous thromboembolism: effect of patient- and D-dimer-related factors on recurrence prediction |
| |
- |
Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism |
| |
- |
Intracranial haemorrhage in haemophilia A and B: an italian retrospective survey |
| |
- |
Central nervous system (CNS) bleeding in patients with rare bleeding disorders (RBDS) |
| |
- |
Does patient sex and prior hormonal therapy predict risk for thrombosis recurrence after a first venous thromboembolism? |
| |
- |
Plasma derived (PD) and recombinant (R) factor VIII (FVIII) concentrates induce a different rate of inhibitor development in hemophilia A patients. a systematic review of the literature |
| |
- |
Factor VIII gene (F8) mutations as a predictor of outcome in immune tolerance induction (ITI) in hemophilia A patients with high-responding inhibitors |
| |
- |
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the two coagulation disorders |
| Iorio M. |
- |
Angiotensin II induces the expression of procoagulant microparticles by human monocytes/macrophages |
| Iorio A. |
- |
Venous thromboembolism recurrence after a first episode of provoked venous thrombosis due to a transient risk factor. A systematic review of the literature |
| |
- |
Computer assisted VKA monitoring with point of care device by general practitioners |
| |
- |
Prospective assessment of clinical endpoints of VKA treatment in a primary care computer assisted management model |
| |
- |
Does the clinical presentation of venous thromboembolism predict the risk for and type of thrombosis recurrence? |
| Iotti M. |
- |
The risk of venous thromboembolic events after splenectomy. prospective observational cohort study in 412 consecutive patients |
| Ippolito L. |
- |
Immune tolerance induction with FVIII/VWF concentrate in an elderly severe haemophilia A patient with high-responding inhibitor |
| Iqbal O. |
- |
Upregulation of procalcitonin in cancer patients with venous thrombosis |
| |
- |
Tadalafil in patients with erectile dysfunction and cardiovascular risk factors: effects on platelets and endothelium |
| |
- |
Defibrotide augments the anticoagulant actions of heparin and low molecular weight heparins |
| |
- |
Differential effects of generic argatrobans on the PT/INR |
| |
- |
Differential effects of generic argatrobans on whole blood activation and thrombin generation markers |
| |
- |
Inflammation and endothelial dysfunction in depression: factors contributing to cardiovascular disease co-morbidity |
| |
- |
Fibrinokinetic deficit in chronic kidney disease and end stage renal disease patients contributes to the hemostatic abnormalities |
| |
- |
Fibrin clot formation differs in the presence of branded and generic enoxaparins |
| |
- |
Molecular and functional heterogeneity in contaminants isolated from recalled heparin. Impact on anticoagulation and potential adverse reactions |
| |
- |
Plasma markers of endothelial cell activation in patients with secondary pulmonary hypertension related to connective tissue diseases: effect of bosentan |
| |
- |
A higher prevalence of hit antibodies in hemodialysis patients may be due to contaminated heparin |
| |
- |
Selective serotonin reuptake inhibitors influence agonist-induced platelet aggregation. preliminary results from comorbidity of depression and cardiovascular disease study |
| |
- |
Assay dependent variations in the USP potency standardized unfractionated heparins |
| |
- |
Generic versions of argatroban can be differentiated from branded argatroban in the thrombin generation assays (TGA) |
| |
- |
Activation of prekallikrein by contaminated heparins, isolated contaminant and related hypersulfated chondroitin sulfate preparations: pharmacologic implications |
| |
- |
Comparative immunogenic potentials of crude and purified bovine thrombin preparations |
| Irigoyen M.B. |
- |
A flow cytometry evaluation of anti-FVIII antibodies: correlation with ELISA and Bethesda assays |
| Ironside J.W. |
- |
Detection of PrPSc in the spleen of an adult haemophilic patient in the UK |
| Ironside J. |
- |
Extent of exposure to and risk stratification of UK patients reated with plasma concentrates with contribution from a donor who developed vCJD |
| Isaev V.A. |
- |
Polyunsaturated fatty acids, vitamin E, and coenzym Q10 in therapy of metabolic syndrome |
| Isarria S. |
- |
D-dimer and short-term clinical outcome of pulmonary embolism: role of pulmonary artery clot load |
| Isbister G.K. |
- |
A quantitative model for the humoral coagulation network |
| Isbister G. |
- |
Endogenous thrombin potential as a novel method for characterisation of procoagulant snake venoms |
| Iscoe S. |
- |
Thromboelastographic (TEG) evaluation of hemostasis in a rat model of obstructive sleep apnea |
| Iserbyt B.F. |
- |
Different binding characteristics of the integrin alpha 2 beta 1 due to I-domain mutations |
| |
- |
Influence of the novel interactors Slap-2 and RhoGDI-beta on integrin alpha2beta1 binding |
| Isermann B. |
- |
In-vitro selection and characterisation of DNA-aptamers that specifically bind to human activated protein c |
| |
- |
Hypercoagulability promotes plaque stability during atherogenesis by inhibiting monocyte migration through a PAR-1, PLC-β, PI3K, and no-dependent mechanism |
| |
- |
Cross-coupling of the transcription factors NF-E2 and AP-1 regulates cell-autonomously trophoblast syncytium formation and placental vascularisation |
| Ishibashi T. |
- |
PKC-MMP-14 axis regulates endothelial soluble Tie-2 (sTie-2) production: involvement of stie-2 in diabetes mellitus-associated vascular complications |
| Ishida N. |
- |
Clock regulates circadian platelet activity |
| Ishida H. |
- |
Local distribution of cytosolic calcium ion in platelet forming thrombi on collagen fibrils and von Willebrand factor under controlled blood flow condition |
| Ishihara C. |
- |
Development of human artificial chromosome vectors for gene therapy of hemophilia A |
| Ishii H. |
- |
Intracellular cyclic amp up-regulates expression of thrombin-activatable fibrinolysis inhibitor (TAFI) in cultured human hepatoma HEPG2 cells |
| Ishii M. |
- |
Use of the platelet indices for differential diagnosis of pediatric immune thrombocytopenic purpura (ITP) |
| Ishii H. |
- |
Racial differences in thrombotic status may explain the increased incidence of haemorrhagic stroke in Japan |
| Ishiwata A. |
- |
The cHS-4 chromatin insulator sequence protects clonal dominance of hematopoietic stem cells transduced with a self-inactivating SIV vector in platelet-directed gene therapy |
| Ishiwata S. |
- |
Activated protein C (APC) promotes proliferation of rat keratinocytes via activation of protease-activated receptor1 (PAR1) and endothelial protein C receptor (EPCR) |
| |
- |
Activated protein c inhibits histamine release and activation of nf-kb in mast cell from rats under normal conditions and acute inflammation |
| Ishiwata A. |
- |
Intrathymic administration of factor VIII results in immune tolerance by induction of factor VIII-specific regulatory T cells in murine hemophilia A |
| Ishiwata S. |
- |
Activated protein C prevents the NF-κB activation at glutamate- and thrombin- induced toxicity |
| Iskas M.S. |
- |
Genetic polymorphism of blood coagulation factor IX gene in greek patients with thrombophilia |
| Isma N. |
- |
Epidemiology of and risk factors for upper extremity venous thrombosis in the population-based malmo trombophilia study (MATS) |
| Isonishi A. |
- |
Identification of 41 Japanese patients with upshaw-shulman syndrome, with special reference to its genotype-phenotype analysis |
| Israel-Biet D. |
- |
Imbalance between circulating endothelial cells and progenitors in primitive and post embolic pulmonary hypertension |
| Israels S. |
- |
Does heterogeneity in measured calibrated thrombin generation assay or FVIII activity (<1%) explain clinical heterogeneity in severe hemophilia A? |
| |
- |
The interpretation of light transmittance platelet aggregation is inconsistent – results from an international challenge |
| |
- |
Long term (10 year) results from the canadian hemophilia primary prophylaxis study |
| Israels S.J. |
- |
Palmitoylation supports the association of tetraspanin CD63 with CD9 and with the actin cytoskeleton in thrombin-activated platelets |
| Israels S. |
- |
Risk factors of bleeding severity in young boys with severe hemophilia a on tailored prophylaxis: long-term (10-year) results from the Canadian hemophilia primary prophylaxis study |
| Italiano J.E. |
- |
Examination of the final stages of platelet production |
| |
- |
Differential roles of cAMP and cGMP in megakaryocyte maturation and platelet formation |
| Italiano Jr J.E. |
- |
Selective sorting of alpha-granule proteins |
| Italiano Jr J. |
- |
Megakaryocytes and thrombopoiesis |
| Itani M. |
- |
The avail me project: a first regional evaluation of venous thromboembolism (VTE) risk and prophylaxis practice |
| Ithychanda S. |
- |
The migfilin-filamin interaction regulates integrin activation |
| Ito N. |
- |
Determination of PT-INR by new portable device (CoaguCheck XS) |
| Ito T. |
- |
Endothelial thrombin-thrombomodulin in vascular system bounds and cleaves HMGB1, and prevents systemic inflammation and intravascular coagulation |
| Ito N. |
- |
National questionnaire survey of TMA |
| Ito H. |
- |
Biochemical and pharmacological properties of ASP1645, a novel selective P2Y12 receptor antagonist |
| |
- |
The antiplatelet effect of ASP1645, a novel P2Y12 receptor antagonist, compared with clopidogrel |
| Ito Y. |
- |
A heterozygous ITGA2B R995W mutation causes constitutive activation of the αIIb/β3 receptor and results in congenital macrothrombocytopenia |
| |
- |
Urokinase-type plasminogen activator induces hepatic differentiation of embryonic stem cell. |
| Ito N. |
- |
Elevated levels of soluble fibrin in patients with venous thromboembolism |
| Ito M. |
- |
Elevated levels of soluble fibrin in patients with venous thromboembolism |
| Itoh H. |
- |
Could D-dimer in the type 2 diabetic patients be a marker of the macrovascular complications? |
| Ittah M. |
- |
Increased levels of circulating microparticles in autoimmune diseases and relation to disease activity |
| Itzhar N. |
- |
Distribution of von Willebrand disease (VWD) types in 94 families from the French National Reference Center for VWD (CRMW) : type 1 is not the most frequent within ‘true’ VWD |
| Ivanciu L. |
- |
Zymogen-like factor Xa variants improve hemostasis in hemophilia mice |
| |
- |
Novel factor XA variants for improving hemostasis in hemophilia |
| |
- |
Expression of hemostatic proteins in the lymphatic vasculature of healthy and septic baboons |
| Ivandic B.T. |
- |
Platelet aggregation and endogenous thrombin capacity (ETC) are not increased in patients after heart transplantation |
| Ivaskevicius V. |
- |
Structural analysis of six novel coagulation factor XIII subunit a missense mutations |
| Iversen P.O. |
- |
Increased acquired activated protein C resistance in unselected patients with hematologic malignancies |
| |
- |
Regulators of extracellular matrix turnover are not strongly correlated with hemostatic parameters in patients with hematologic malignancies |
| Iversen N. |
- |
Regulators of extracellular matrix turnover are not strongly correlated with hemostatic parameters in patients with hematologic malignancies |
| |
- |
Functional studies of the 5′UTR and intron 7 SNPs of the TFPI gene |
| |
- |
Knock down of TFPI expression in SUM102 breast cancer cells leads to pro-angiogenic phenotypes |
| |
- |
Mechanism underlying protein C deficiency in a patient with an ALA267THR mutation |
| Iwade M. |
- |
Decrease of intraoperative transfusion, especially fresh frozen plasma, during cardiovascular surgery leads to decrease the risk of the postoperative infection |
| Iwade K. |
- |
Decrease of intraoperative transfusion, especially fresh frozen plasma, during cardiovascular surgery leads to decrease the risk of the postoperative infection |
| Iwahashi H. |
- |
Determination of PT-INR by new portable device (CoaguCheck XS) |
| Iwai T. |
- |
Are platelets phagocytes or covercytes? An ultrastructural study of interaction between Porphyromonas gingivalis, an oral bacterium and human platelets |
| Iwaki T. |
- |
A plasminogen deficiency attenuates atherosclerosis as a result of altered lipoprotein processing |
| Iwaniec T. |
- |
Tumour necrosis factor alfa and soluble interleukin 2 receptor (sIL-2R) levels in patients with antiphospholipid syndrome |
| |
- |
Functional variants of platelet glycoproteins Ia/IIa and IIb/IIIa and valine/leucine247 polymorphism of beta 2- glycoprotein i and a risk of arterial thrombosis in patients with antiphosholipid syndrome |
| |
- |
Arterial thrombosis in patients with antiphosholipid syndrome |
| |
- |
Fibrinogen Krakow: a heterozygous case of a novel hypodysfibrinogenemia (gAsn325Ile) affecting fibrin architecture and function |
| |
- |
A common genetic variant of factor xiii a subunit Val34leu predisposes to venous thrombosis in patients with antiphospholipid syndrome |
| |
- |
Microparticles’ procoagulant activity and sCD40L concentration during pregnancy in healthy women and women with antiphospholipid syndrome |
| |
- |
Endothelial dysfunction and TNF-alpha in young men with multiple cardiovascular risk factors |
| |
- |
Improvement of endothelial function and reduction of proinflammatory markers in simvastatin treatment |
| |
- |
Strong bleeding tendency in a family with moderate thrombocytopenia – laboratory diagnostic work-up of seven family members |
| Iwasaka T. |
- |
Adiponectin-dependent effects of pitavastatin on platelet-derived microparticles, soluble CD40 ligand and MCP-1 in hyperlipidemic patients |
| Iwata H. |
- |
Gamma-glutamyl carboxylase is a cargo receptor for vitamin K-dependent proteins |
| Iyu D. |
- |
Harnessing the antiplatelet effects of prostaglandin E2 by EP3 receptor blockade |
| Izaguirre R.A. |
- |
Fibrin polymerization rate (FPR) as a cardiovascular risk factor and coronary risk predictor |
| |
- |
Factor VIIIC as cardiovascular risk in DM2 subjects and coronary heart disease |
| Izzi B. |
- |
Platelet activation and platelet-leukocyte mixed conjugates in patients with atrial fibrillation |
| |
- |
Possible role of GNAS1 imprinting in a prothrombotic phenotype: NESP55 hypermethylation in ischemic stroke at young age |
| |
- |
Human platelet pathology related to defects in the G-protein signalling cascade |
